What causes Rheumatoid Arthritis of the Eye (RAE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Rheumatoid Arthritis of the Eye (RAE)

Rheumatoid arthritis of the eye is caused by autoimmune-mediated inflammation that extends from systemic rheumatoid arthritis to ocular tissues, resulting in inflammatory eye diseases including keratoconjunctivitis sicca, episcleritis, scleritis, and peripheral ulcerative keratitis. 1

Primary Pathophysiologic Mechanism

The ocular manifestations of rheumatoid arthritis represent extra-articular complications of the systemic autoimmune disease, where the same inflammatory processes affecting joints extend to ocular structures. 1, 2

  • Autoimmune-mediated tissue damage on the ocular surface occurs through defects in innate immunity, including Toll-like receptors, S100A proteins, and resident antigen-presenting cells. 3
  • Cytokines, chemokines, and T helper cell subsets (particularly TH1 and TH17) drive the inflammatory cascade that damages ocular tissues. 3
  • Systemic vasculitis associated with RA can lead to the most severe ocular complications, including necrotizing scleritis and peripheral ulcerative keratitis, which are associated with excess mortality. 1

Specific Ocular Conditions and Their Causes

Keratoconjunctivitis Sicca (Dry Eye)

  • Most common ocular manifestation of RA, occurring more frequently and with greater clinical severity than idiopathic dry eye. 4, 3
  • Caused by autoimmune destruction of lacrimal gland tissue and inflammatory disruption of tear film production. 3

Episcleritis and Scleritis

  • Episcleritis affects approximately 5% of RA patients and represents inflammatory involvement of superficial episcleral vessels. 4
  • Scleritis occurs in approximately 2% of RA patients, with RA being the leading cause of necrotizing scleritis. 1, 4
  • Nodular scleritis results from inflammatory nodule formation within scleral tissue. 4

Peripheral Ulcerative Keratitis (PUK)

  • RA is the leading cause of PUK, representing one of the two most severe ocular conditions associated with the disease. 1
  • Caused by inflammatory destruction of peripheral corneal stroma adjacent to sites of inflammation, often associated with systemic vasculitis. 4

Retinal Vasculitis

  • Occurs in approximately 0.45% of RA patients and represents inflammatory involvement of retinal blood vessels. 4
  • Associated with systemic vasculitic manifestations of RA. 4

Important Clinical Context

The ocular inflammation can occur at a different time from articular disease, meaning eye involvement may precede, coincide with, or follow joint symptoms. 3 This is critical because:

  • Ocular manifestations can be the first signs of rheumatoid arthritis in some patients. 1
  • The severity of ocular involvement does not always correlate with the severity of joint disease. 3
  • Necrotizing scleritis and PUK rapidly threaten ocular prognosis and require urgent recognition and treatment. 1

Key Pitfall to Avoid

Do not assume that well-controlled joint disease means the eyes are protected—ocular surface immune factors can be influenced by the systemic immune landscape but may require independent monitoring and treatment. 3 Close collaboration between ophthalmology and rheumatology is essential for diagnosis and management. 1, 2

References

Research

Ocular manifestations of rheumatoid arthritis.

Current opinion in ophthalmology, 2022

Research

The eye: a window of opportunity in rheumatoid arthritis?

Nature reviews. Rheumatology, 2014

Research

Ocular manifestation of rheumatoid arthritis-different forms and frequency.

Bosnian journal of basic medical sciences, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.